Evidence map›Paper›PMID 32376888›Full record

SynthesisBritish journal of cancer2020

Exogenous hormone use, reproductive factors and risk of intrahepatic cholangiocarcinoma among women: results from cohort studies in the Liver Cancer Pooling Project and the UK Biobank.

Jessica L Petrick, Úna C McMenamin, Xuehong Zhang, Anne Zeleniuch-Jacquotte, Jean Wactawski-Wende, Tracey G Simon, Rashmi Sinha, Howard D Sesso, Catherine Schairer, Lynn Rosenberg and 28 more

Open access · hybridAbstract readMeta-Analysis
In one paragraph

Synthesis in British journal of cancer, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 27 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
27citing papers in PubMed, 2 pooled it
4.1field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

27 citing papers in PubMed, 2 syntheses or guidelines pooled it, 40 citations in OpenAlex.

  1. Pooled it
  2. Guideline
  3. Sexual dimorphism in the liver.Nature reviews. Gastroenterology & hepatology · 2026
    Review
  4. Article
  5. Review
  6. Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Review
  12. Mucinous cystic neoplasms of the pancreas demonstrateFrontiers in cell and developmental biology · 2025
    Article
  13. Review
  14. Review
  15. Article
  16. Article
  17. Article
  18. An Examination of Liver Cancer Incidence in California.Journal of registry management · 2024
    Article
  19. RETRACTED: Menstrual Factors, Reproductive History and Liver Cancer Risk: Findings from a Prospective Cohort Study in Chinese Women.Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology · 2022
    Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

38 authors at 17 institutions in 4 countries.

Jessica L Petrick *Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, MD, USA. jpetrick@bu.edu.
Úna C McMenamin *Centre for Public Health, Queen's University Belfast, Belfast, Northern Ireland, UK.
Xuehong ZhangChanning Division of Network Medicine, Brigham and Women's Hospital, Boston, MA, USA.
Anne Zeleniuch-JacquotteDepartment of Population Health, New York University School of Medicine, New York, NY, USA.
Jean Wactawski-WendeDepartment of Epidemiology and Environmental Health, University at Buffalo, Buffalo, NY, USA.
Tracey G SimonDivision of Gastroenterology, Massachusetts General Hospital and Harvard Medical School, Boston, MA, USA.
Rashmi SinhaDivision of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, MD, USA.
Howard D SessoDepartment of Epidemiology, Harvard T.H. Chan School of Public Health, Boston, MA, USA.
Catherine SchairerDivision of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, MD, USA.
Lynn RosenbergSlone Epidemiology Center, Boston University, Boston, MA, USA.
Thomas E RohanDepartment of Epidemiology & Population Health, Albert Einstein College of Medicine, Bronx, NY, USA.
Kim RobienDepartment of Exercise and Nutrition Sciences, Milken Institute School of Public Health, George Washington University, Washington, DC, USA.
Mark P PurdueDivision of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, MD, USA.
Jenny N PoynterDivision of Pediatric Epidemiology and Clinical Research and Masonic Cancer Center, University of Minnesota, Minneapolis, MN, USA.
Julie R PalmerSlone Epidemiology Center, Boston University, Boston, MA, USA.
Yunxia LuDepartment of Population Health and Disease Prevention, Program in Public Health, University of California, Irvine, Irvine, CA, USA.
Martha S LinetDivision of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, MD, USA.
Linda M LiaoDivision of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, MD, USA.
I-Min LeeDepartment of Epidemiology, Harvard T.H. Chan School of Public Health, Boston, MA, USA.
Jill KoshiolDivision of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, MD, USA.
Cari M KitaharaDivision of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, MD, USA.
Victoria A KirshEpidemiology Division, Dalla Lana School of Public Health, University of Toronto, Toronto, Ontario, Canada.
Jonathan N HofmannDivision of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, MD, USA.
Barry I GraubardDivision of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, MD, USA.
Edward GiovannucciDepartment of Epidemiology, Harvard T.H. Chan School of Public Health, Boston, MA, USA.
J Michael GazianoDivision of Preventive Medicine, Department of Medicine, Brigham and Women's Hospital, Boston, MA, USA.
Susan M GapsturBehavioral and Epidemiology Research Group, American Cancer Society, Atlanta, GA, USA.
Neal D FreedmanDivision of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, MD, USA.
Andrea A FlorioDivision of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, MD, USA.
Dawn Q ChongDivision of Medical Oncology, National Cancer Centre, Singapore, Singapore.
Yu ChenDepartment of Population Health, New York University School of Medicine, New York, NY, USA.
Andrew T ChanChanning Division of Network Medicine, Brigham and Women's Hospital, Boston, MA, USA.
Julie E BuringDepartment of Epidemiology, Harvard T.H. Chan School of Public Health, Boston, MA, USA.
Laura E Beane FreemanDivision of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, MD, USA.
Jennifer W BeaDepartment of Medicine, University of Arizona, Tucson, AZ, USA.
Christopher R CardwellCentre for Public Health, Queen's University Belfast, Belfast, Northern Ireland, UK.
Peter T CampbellBehavioral and Epidemiology Research Group, American Cancer Society, Atlanta, GA, USA.
Katherine A McGlynnDivision of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, MD, USA.
Division of Cancer Epidemiology and GeneticsNational Cancer Institute · USHarvard University · USBrigham and Women's Hospital · USAmerican Cancer Society · USBoston University · USNew York University · USQueen's University Belfast · GBAlbert Einstein College of Medicine · USGeorge Washington University · USNational Cancer Centre Singapore · SGUniversity at Buffalo, State University of New York · USUniversity of Arizona · USUniversity of California, Irvine · USUniversity of Minnesota Medical Center · USUniversity of Toronto · CAVA Boston Healthcare System · US

Funding

Vaccine FacilityP30CA016087 · NCI · NEW YORK UNIVERSITY SCHOOL OF MEDICINE · PI Richard Lewis Possemato · 1985 to 2026
$83.1M
Tissue and Pathology ResourcesP50CA127003 · NCI · DANA-FARBER CANCER INST · PI BASS, ADAM JOEL · 2007 to 2023
$33.2M
RESEARCH IN ENVIRONMENTAL HEALTH SCIENCES (CENTER GRANT)P30ES000260 · NIEHS · NEW YORK UNIVERSITY SCHOOL OF MEDICINE · PI ZELIKOFF, JUDITH TERRY · 1985 to 2020
$26.1M
A Follow-up Study for Causes of Cancer in Black WomenU01CA164974 · NCI · BOSTON UNIVERSITY MEDICAL CAMPUS · PI Kimberly A. Bertrand, Yvette C Cozier · 2017 to 2026
$24.0M
Long Term Multidisciplinary Study of Cancer in Women: The Nurses Health StudyUM1CA186107 · NCI · BRIGHAM AND WOMEN'S HOSPITAL · PI ELIASSEN, A. HEATHER, STAMPFER, MEIR · 2014 to 2023
$22.3M
FOLLOW-UP STUDY FOR CAUSES OF ILLNESS IN BLACK WOMENR01CA058420 · NCI · BOSTON UNIVERSITY MEDICAL CAMPUS · PI ROSENBERG, LYNN · 1999 to 2013
$20.7M
Studies of Rare CancersZIACP010158 · NCI · DIVISION OF CANCER EPIDEMIOLOGY AND GENETICS · PI MCGLYNN, KATHERINE · 2009 to 2025
$19.1M
Cancer Epidemiology Cohort in Male Health ProfessionalsUM1CA167552 · NCI · HARVARD SCHOOL OF PUBLIC HEALTH · PI WILLETT, WALTER C. · 2012 to 2016
$11.5M
The NYU Women's Health StudyUM1CA182934 · NCI · NEW YORK UNIVERSITY SCHOOL OF MEDICINE · PI ZELENIUCH-JAQUOTTE, ANNE · 2015 to 2019
$3.7M
The NYU Women's Health StudyU01CA182934 · NCI · NEW YORK UNIVERSITY SCHOOL OF MEDICINE · PI CHEN, YU · 2020 to 2023
$2.7M
Calcium and Colorectal Cancer: Gene-Environment Interactions and Molecular PathwaysK07CA188126 · NCI · BRIGHAM AND WOMEN'S HOSPITAL · PI ZHANG, XUEHONG · 2015 to 2018
$576k
Cancer Research UK 20100Medical Research Council MC_PC_17228Medical Research Council MC_QA137853Medical Research Council MR/T019859/1NCI NIH HHS K07 CA188126NCI NIH HHS P30 CA016087NCI NIH HHS P50 CA127003NCI NIH HHS R01 CA058420NCI NIH HHS U01 CA164974NCI NIH HHS U01 CA182934NCI NIH HHS UM1 CA167552NCI NIH HHS UM1 CA182934NCI NIH HHS UM1 CA186107NHLBI NIH HHS HHSN268201600001CNHLBI NIH HHS HHSN268201600002CNHLBI NIH HHS HHSN268201600003CNHLBI NIH HHS HHSN268201600004CNHLBI NIH HHS HHSN268201600018CNIEHS NIH HHS P30 ES000260
6 · The paper itself

Abstract

backgroundIntrahepatic cholangiocarcinoma (ICC) arises from cholangiocytes in the intrahepatic bile duct and is the second most common type of liver cancer. Cholangiocytes express both oestrogen receptor-α and -β, and oestrogens positively modulate cholangiocyte proliferation. Studies in women and men have reported higher circulating oestradiol is associated with increased ICC risk, further supporting a hormonal aetiology. However, no observational studies have examined the associations between exogenous hormone use and reproductive factors, as proxies of endogenous hormone levels, and risk of ICC.

methodsWe harmonised data from 1,107,498 women who enroled in 12 North American-based cohort studies (in the Liver Cancer Pooling Project, LCPP) and the UK Biobank between 1980-1998 and 2006-2010, respectively. Cox proportional hazards regression models were used to generate hazard ratios (HR) and 95% confidence internals (CI). Then, meta-analytic techniques were used to combine the estimates from the LCPP (n = 180 cases) and the UK Biobank (n = 57 cases).

resultsHysterectomy was associated with a doubling of ICC risk (HR = 1.98, 95% CI: 1.27-3.09), compared to women aged 50-54 at natural menopause. Long-term oral contraceptive use (9+ years) was associated with a 62% increased ICC risk (HR = 1.62, 95% CI: 1.03-2.55). There was no association between ICC risk and other exogenous hormone use or reproductive factors.

conclusionsThis study suggests that hysterectomy and long-term oral contraceptive use may be associated with an increased ICC risk.

Indexed as

AgedBile DuctsBile Ducts, IntrahepaticBiological Specimen BanksCholangiocarcinomaCohort StudiesContraceptives, Oral, HormonalEstrogen Receptor alphaEstrogen Receptor betaFemaleGene Expression Regulation, NeoplasticHormonesHumansHysterectomyLiver NeoplasmsMenopauseContraceptives, Oral, HormonalESR1 protein, humanESR2 protein, humanEstrogen Receptor alphaEstrogen Receptor betaHormones

Identifiers

PMID32376888
PMCPMC7374167
OpenAlexW3015521901

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.